483
Impact Clinical TrialsImpact Clinical Trials – FDA 483, Feb 11, 2010
Record Details
An FDA inspection of Impact Clinical Trials in Los Angeles, CA, revealed significant deficiencies in their conduct of clinical trials. The firm failed to ensure proper informed consent, including not providing critical errata to numerous subjects and using unreadable consent forms. Additionally, the inspection found issues with investigator oversight, as sub-investigators were not properly listed on FDA-1572 forms or did not sign required financial disclosure forms.
View Company Profile
ID · 3fc658b4-912d-483f-aea5-6ebe447bbdea
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.